Can-Fite BioPharma Ltd. (CANF.TA)
ILA 1.6
(6.67%)
ILA 1.6
(6.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 743 Thousand | 810 Thousand | 853 Thousand | 763 Thousand | 2.03 Million | 3.82 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 743 Thousand | 810 Thousand | 853 Thousand | 763 Thousand | 2.03 Million | 3.82 Million |
| Operating Expenses | 8.93 Million | 10.9 Million | 13.69 Million | 14.9 Million | 14.03 Million | 9.23 Million |
| Selling, General and Administrative Expenses | 2.95 Million | 3.14 Million | 3.84 Million | 2.95 Million | 3.06 Million | 3.15 Million |
| Research and Development Expenses | 5.98 Million | 7.76 Million | 9.85 Million | 11.95 Million | 10.97 Million | 6.07 Million |
| Other Expenses | - | - | - | - | - | 109 Thousand |
| Cost and Expenses | 8.93 Million | 10.9 Million | 13.69 Million | 14.9 Million | 14.03 Million | 9.23 Million |
| Operating Income | -8.19 Million | -10.09 Million | -12.84 Million | -14.13 Million | -12 Million | -5.41 Million |
| Interest Expense | 14 Thousand | 77 Thousand | 18 Thousand | 363 Thousand | 427 Thousand | 1.2 Million |
| Income Tax Expense | - | 360 Thousand | -20 Thousand | 363 Thousand | 427 Thousand | 4000.00 |
| Earnings before Tax | -7.63 Million | -10.17 Million | -12.61 Million | -14.44 Million | -12.62 Million | -6.56 Million |
| Net Income | -7.63 Million | -10.53 Million | -12.59 Million | -14.8 Million | -13.05 Million | -6.57 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.02 | -0.04 | -0.15 | -0.17 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.02 | -0.04 | -0.15 | -0.17 |
| Weighted Average Shares Outstanding | 1.27 Billion | 815.74 Million | 553.07 Million | 358.41 Million | 85.9 Million | 38.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.27 Billion | 815.74 Million | 553.07 Million | 358.41 Million | 85.9 Million | 38.9 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -11.01 | -12.46 | -15.06 | -18.49 | -5.88 | -1.40 |
| Profit Margin | -10.27 | -13.00 | -14.77 | -19.40 | -6.42 | -1.72 |
| EBITDA | -8.18 Million | -10.08 Million | -12.82 Million | -14.12 Million | -11.99 Million | -6.12 Million |
| Earnings Before Tax Margin | -11.03 | -12.46 | -15.06 | -18.53 | -5.91 | -1.42 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 743 Thousand | 155 Thousand | 196 Thousand | 196 Thousand | 196 Thousand | 810 Thousand |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 743 Thousand | 155 Thousand | 196 Thousand | 196 Thousand | 196 Thousand | 810 Thousand |
| Operating Expenses | 8.93 Million | 1.98 Million | 2.06 Million | 1.98 Million | 2.9 Million | 10.9 Million |
| Selling, General and Administrative Expenses | - | 722 Thousand | 762 Thousand | 624 Thousand | 847 Thousand | - |
| Research and Development Expenses | - | 1.26 Million | 1.29 Million | 1.35 Million | 2.06 Million | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 8.93 Million | 1.98 Million | 2.06 Million | 1.98 Million | 2.9 Million | 10.9 Million |
| Operating Income | -8.19 Million | -1.83 Million | -1.86 Million | -1.78 Million | -2.71 Million | -10.09 Million |
| Interest Expense | - | - | - | - | -162 Thousand | 77 Thousand |
| Income Tax Expense | -561 Thousand | -3750.00 | -3500.00 | -4000.00 | -162 Thousand | 360 Thousand |
| Earnings before Tax | -7.63 Million | -1.65 Million | -1.76 Million | -1.67 Million | -2.55 Million | -10.17 Million |
| Net Income | -7.63 Million | -1.65 Million | -1.76 Million | -1.67 Million | -2.38 Million | -10.53 Million |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 1.27 Billion | 1.48 Billion | 1.22 Billion | 1.17 Billion | 1.17 Billion | 815.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.27 Billion | 1.48 Billion | 1.22 Billion | 1.17 Billion | 1.17 Billion | 815.74 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | -11.83 | -9.52 | -9.10 | -13.84 | - |
| Profit Margin | -10.27 | -10.66 | -8.99 | -8.52 | -12.18 | -13.00 |
| EBITDA | - | -1.83 Million | -1.86 Million | -1.78 Million | -2.71 Million | - |
| Earnings Before Tax Margin | -11.03 | -11.83 | -9.52 | -9.10 | -13.84 | -12.46 |
OMIP
PRU
VNWTF
2694
5984
PFD